Marcin Pyrski

Mr. Marcin Pyrski

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2019 in Vaccines
Verified
Journal Article
Open access
PDF file
MPMarcin Pyrski
Marcin Pyrski
AMAdam Mieloch
Adam Mieloch
APAdam Plewiński
Adam Plewiński
ABAneta Basińska-Barczak
Aneta Basińska-Barczak
AGAleksandra Gryciuk
Aleksandra Gryciuk
Tomasz PniewskiTomasz Pniewski
Tomasz Pniewski
Chronic hepatitis B (CHB) is the cause of severe liver damage, cirrhosis, and hepatocellular carcinoma for over 240 million people worldwide. Nowadays, several types of treatment are being investigated, including immunotherapy using hepatitis B core antigen (HBcAg) assembled into highly immunogenic capsid-like particles (CLPs). Immunogenicity of plant-produced and purified HBcAg, administered parenterally or intranasally, was previously reported. In this study, a novel parenteral–oral vaccination scheme is proposed using plant-derived HBcAg preparations. The antigen for injection was obtained via transient expression in Nicotiana benthamiana. HBcAg-producing transgenic lettuce was lyophilized and used as an orally delivered booster. The intracellular location of plant-produced HBcAg CLPs implies additional protection in the digestive tract during oral immunization. BALB/c mice were intramuscularly primed with 10 µg of the purified antigen and orally boosted twice with 5 or 200 ng of HBcAg. A long-lasting and significant systemic response after boosting with 200 ng HBcAg was induced, with anti-HBc titer of 25,000. Concomitantly, an insignificant mucosal response was observed, with an S-IgA titer of only 500. The profile of IgG isotypes indicates a predominant Th1 type of immune response, supplemented by Th2, after injection–oral vaccination. The results demonstrate that a low dose of parenteral–oral immunization with plant-derived HBcAg can elicit a specific and efficient response. This study presents a potential new pathway of CHB treatment.

1 October 2017 in Vaccine
Verified
Journal Article
Closed access
MPMarcin Pyrski
Marcin Pyrski
ARAnna Rugowska
Anna Rugowska
KWKamil Robert Wierzbiński
Kamil Robert Wierzbiński
AKAnna Kasprzyk
Anna Kasprzyk
MBMaria Bogusiewicz
Maria Bogusiewicz
Tomasz PniewskiTomasz Pniewski
Tomasz Pniewski

26 January 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Jakub Dalibor RybkaJakub Dalibor Rybka
Jakub Dalibor Rybka
AMAdam Mieloch
Adam Mieloch
APAlicja Plis
Alicja Plis
MPMarcin Pyrski
Marcin Pyrski
Tomasz PniewskiTomasz Pniewski
Tomasz Pniewski
MGMichael Giersig
Michael Giersig
Core-virus like particles (VLPs) assembly is a kinetically complex cascade of interactions between viral proteins, nanoparticle’s surface and an ionic environment. Despite many in silico simulations regarding this process, there is still a lack of experimental data. The main goal of this study was to investigate the capsid protein of hepatitis B virus (HBc) assembly into virus-like particles with superparamagnetic iron oxide nanoparticles (SPIONs) as a magnetic core in relation to their characteristics. The native form of HBc was obtained via agroinfection of Nicotiana benthamiana with pEAQ-HBc plasmid. SPIONs of diameter of 15 nm were synthesized and functionalized with two ligands, providing variety in ζ-potential and hydrodynamic diameter. The antigenic potential of the assembled core-VLPs was assessed with enzyme-linked immunosorbent assay (ELISA). Morphology of SPIONs and core-VLPs was evaluated via transmission electron microscopy (TEM). The most successful core-VLPs assembly was obtained for SPIONs functionalized with dihexadecyl phosphate (DHP) at SPIONs/HBc ratio of 0.2/0.05 mg/mL. ELISA results indicate significant decrease of antigenicity concomitant with core-VLPs assembly. In summary, this study provides an experimental assessment of the crucial parameters guiding SPION-HBc VLPs assembly and evaluates the antigenicity of the obtained structures.